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ABSTRACT
Dysregulation of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNFα) has been implicated in the pathogenesis of alcoholic liver injury. Sirtuin 1 (SIRT1) is an NAD (+) -dependent class III protein deacetylase that is known to be involved in regulating production of pro-inflammatory cytokines including TNFα. In the present study, we examined the role of SIRT1 signaling in TNFα generation stimulated by either lipopolysaccharide (LPS), acetaldehyde (AcH) or acetate (two major metabolites of ethanol) in two cultured macrophage cell lines. In both rat Kupffer cell line 1 (RKC1) and murine RAW 264.7 macrophages, treatment with either LPS, AcH or acetate caused significant decreases in SIRT1 transcription, translation and activation, which essentially demonstrated an inverse relationship with TNFα levels. LPS, AcH and acetate each provoked the release of TNFα from RKC1 cells, while co-incubation with resveratrol (a potent SIRT1 agonist) inhibited this effect. Conversely, addition of sirtinol (a known SIRT1 inhibitor) or knocking down SIRT1 by the small silencing SIRT1 plasmid (SIRT1shRNA) augmented TNFα release, suggesting that impairment of SIRT1 may contribute to TNFα secretion. Further mechanistic studies revealed that inhibition of SIRT1 by LPS, AcH or acetate was associated with a marked increase in the acetylation of the RelA/p65 subunit of nuclear transcription factor (NF-κB) and promotion of NF-κB transcriptional activity. Taken together, our findings suggest that SIRT1-NF-κB signaling is involved in regulating LPS-and metabolites-of-ethanol-mediated TNFα production in rat Kupffer cells and in murine macrophages. Our study provides new insights into
INTRODUCTION
Alcoholic liver disease (ALD) is clinically associated with the development of steatosis, inflammation, and eventually fibrosis and cirrhosis. The underlying cellular and molecular mechanisms by which alcohol causes liver injury are complex and incompletely understood.
Hepatic ethanol metabolism has long been implicated in the development of ALD (22, 23) . Metabolic byproducts of ethanol, such as acetaldehyde (AcH) and acetate have been presumed agents of such damage. Additionally, lipopolysaccharide (LPS), one of the components of the outer wall of gram-negative bacteria, has been thought to participate in the etiology (10, 31) . Chronic ethanol exposure alters gut microflora and permeability, resulting in elevated release of LPS, which enters the liver through the portal vein and activates resident macrophages (Kupffer cells) which release proinflammatory cytokines such as tumor necrosis factor alpha (TNFα), which, in turn, promote liver damage. Meanwhile, a corollary process occurs, in which chronic ethanol feeding sensitizes Kupffer cells to LPS signaling, enhancing LPS-stimulated TNFα production in rodents (31) .
Sirtuin 1 (SIRT1) is an NAD + -dependent class III protein deacetylase that exerts anti-inflammatory effects by deacetylation of modified lysine residues on transcriptional regulators, particularly nuclear transcription factor-kappa B (NF-κB), a master transcription factor involved in regulation of proinflammatory cytokines (29) . SIRT1 physically interacts with and deacetylates the RelA/p65 subunit of NF-κB at lysine 310, and subsequently inhibits NF-κB transcriptional activity (6, 36, 38, 39) . The antiinflammatory action of SIRT1 is further supported by a recent study demonstrating that activation of SIRT1 protects mice from a high fat diet induced hepatic inflammation through decreasing the NF-κB-mediated induction of inflammatory cytokines including TNFα (27) .
Adiponectin is an adipocyte-derived protein that has potent anti-inflammatory properties. ALD is associated with reduced circulating adiponectin levels and impaired hepatic adiponectin signaling (28) . The anti-inflammatory properties of adiponectin have been implicated in the protective action of adiponectin against development of alcoholic liver injury (25) . However, the underlying molecular mechanisms by which adiponectin exerts its protective effects are still not fully understood.
In the present study, we used immortalized rat Kupffer cell line 1 (RKC1) and murine RAW 264.7 macrophages to test the hypothesis that SIRT1 signaling is involved in regulating the TNFα production that is stimulated by three putative inducers of ALD [LPS and two major metabolites of ethanol (AcH and acetate)]. Further, we investigated the corollary hypothesis, that SIRT1 plays a role in adiponectin's suppression of these compounds' abilities to induce TNFα.
MATERIALS AND METHODS

Materials.
Most chemicals and supplies were purchased from Sigma Chemical, Schleicher and Schuell, GIBCO BRL, and Dupont NEN Research Products. Acetate, AcH, LPS (tissue culture-tested, L-2654), and resveratrol were obtained from Sigma.
Sirtinol and splitomicin were purchased from Calbiochem (Gibbstown, NJ). Recombinant human globular adiponectin (gAcrp) was purchased from PeproTech, Inc (Rockyhill, NJ).
Plasmids. NF-B-responsive reporter-3x B luciferase plasmid, wild-type SIRT1 (SIRT1wt) or deacetylase-defective SIRT1(H363Y) mutant expression plasmids were kind gifts from Dr. Marty W Mayo (University of Virginia, Charlottesville, VA) (38) .
The small silencing SIRT1 plasmid (SIRT1shRNA) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Cell culture and treatment. Immortalized rat Kupffer Cell line 1 (RKC1) was established as described previously (26) . The murine RAW264.7 macrophages were obtained from the American Type Culture Collection (Manassas, VA). All cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS), 100 µg/ml streptomycin and 63 µg/ml penicillin G. For treatments, cells were plated onto six-well plates. At 80-90% confluence, the cells were incubated for 16 h in serum-free RPMI 1640 medium. The cells were treated with various reagents for 18 h. For AcH treatment, the culture plates were sealed to prevent the loss of AcH by evaporation.
TNFα assay. TNFα concentration in cell culture media of RKC1 or RAW 264.7 macrophages was measured using a mouse TNFα ELISA kit (eBioscience, San Diego, CA) according to manufacturer's protocol.
Total RNA isolation and real-time quantitative polymerase chain reaction (qRT-PCR).
Total RNA was prepared from cells using an RNAeasy TM Total RNA kit (QIAGEN Inc.).
Reverse transcription of 2 μg total RNA to cDNA was performed using the StrataScript RelA/p65 acetylation assays. RelA/p65 protein was immunoprecipitated from whole cell extracts by a RelA/p65 antibody (Santa Cruz, CA). Acetylation and protein levels of RelA/p65 were detected using antibodies for acetyl-lysine (Cell Signaling, MA) and
RelA/p65, respectively.
Transfections and luciferase assays. Cell transfection assays were carried out as described previously (40, 42) . Briefly, plasmids were transiently transfected into cells using Lipofectamine reagent (Invitrogen, CA). Luciferase assays were carried out using cell extracts, and the results were averaged to represent a single data point for each transfection. β-Galactosidase was used as an internal control to correct for transfection efficiency.
Statistical analysis. Data are presented as the mean±S.E. Multiple comparisons were evaluated by ANOVA followed by Tukey's Multiple Comparison Procedure with p< 0.05 being considered significant.
RESULTS
SIRT1's mRNA, protein and enzymatic activity was reduced by LPS, AcH or acetate in
RKC1 and RAW 264.7 macrophages.
Both RKC1 and murine RAW 264.7 macrophages display many characteristics similar to Kupffer cells, particularly their pathways regulating LPS induced production of TNFα (26, 24) . Further, they each express ample amounts of SIRT1 mRNA and protein ( Fig.1) . Hence, these two cell lines were used to investigate the effects of LPS, AcH and acetate on SIRT1 signaling.
We initially sought to determine the effect of each molecule on the expression and activity of SIRT1. Cells were exposed to various concentrations of LPS, AcH or acetate for 18 h then harvested. SIRT1 protein expression levels were determined utilizing western blotting techniques. In each cell line, treatment with either LPS, AcH or acetate significantly reduced SIRT1 protein levels, with an optimal effect at 100 ng/ml for LPS, 100 μM for AcHh and 20 mM for acetate (Fig.1A&B ). These concentrations did not adversely affect cell viability, and were thus used in subsequent experiments. Next, utilizing qRT-PCR, we determined that treatment with each compound significantly suppressed SIRT1 mRNA expression in both cell types (Fig.1C) . Similarly, SIRT1
deacetylase activity was determined flourimetrically, and shown to be significantly reduced in RKC1 cells following 18h incubation with either LPS, AcH or acetate (Fig.1D ). Taken together, these results provided evidence that LPS, AcH and acetate each inhibit SIRT1's transcription, translation and activation in cultured RKC1 and RAW 264.7 macrophages.
Pharmacological or genetic modulation of SIRT1 regulates TNFα secretion stimulated by LPS, AcH or acetate in RKC1.
We utilized the same treatment protocol to determine the effect of these molecules on TNFα induction. As shown in Fig 2, incubation with LPS, AcH or acetate caused a robust rise in TNFα secretion in RKC1 or RAW 264.7 macrophages.
We then employed pharmacological and genetic manipulations of SIRT1 to study its role in mediating TNFα levels. Pre-treatment of RKC1 cells with 10 μM resveratrol (a potent SIRT1 activator) for 2 h, followed by co-incubation with LPS, AcH or acetate for 18 h significantly attenuated elevations in TNF-α ( (Fig.4A) . However, the cells that were transfected with SIRT1wt displayed significant reduction in the NF-κB transcriptional activity induced by LPS, AcH or acetate. Conversely, co-transfection with the deacetylase-defective SIRT1(H363Y) plasmid modestly increased the effects of LPS, AcH or acetate on NF-κB activity (Fig.4A) . Collectively, these results suggest that the NF-κB transcriptional activity that is induced by LPS-, AcH-or acetate-treatments may be, at least in part, mediated through down-regulating SIRT1 signaling.
LPS, AcH or acetate-mediated inhibition of SIRT1 signaling was associated with increased acetylation of RelA/p65 and enhanced NFκB transcriptional activity.
SIRT1 is capable of inhibiting NF-κB transcriptional activity by deacetylating
RelA/p65 (6, 36, 38) . Therefore, we determined whether LPS-or ethanol metabolites (AcH or acetate)-mediated inhibition of SIRT1 results in hyperacetylation of RelA/p65.
We first examined the physical association of SIRT1 with RelA/p65 of NF-κB by performing co-immunoprecipitation assays in RKC1 cells. In agreement with reported findings (6, 36) , an antibody to SIRT1 co-precipitated RelA/p65 and an antibody to
RelA/p65 co-precipitated SIRT1 from RKC1 cells, suggesting that SIRT1 was physically associated with RelA/p65 ( Together, these data demonstrate that SIRT1 does physically interact with the RelA/p65 subunit of NF-κB, and that inhibition of SIRT1 by LPS or ethanol metabolites (AcH and acetate) leads to hyperacetylation of RelA/p65, activation of NF-κB and potentially increased release of TNFα.
Adiponectin attenuated LPS-or acetate-induced TNFα production through upregulation of SIRT1 in RKC1 and RAW 264.7 macrophages.
The protective effect of adiponectin against ALD has been partially attributed to its ability to suppress LPS-stimulated TNFα production in Kupffer cells (31, 24, 25) .
Hence, we investigated the involvement of SIRT1 signaling in the inhibitory effect of adiponectin on TNFα secretion stimulated by LPS or ethanol metabolites.
Both RKC1 and RAW 264.7 macrophages are more sensitive to globular adiponectin (gAcrp) than to full-length adiponectin (data not shown). Thus, all experiments were carried out with gAcrp. The effect of gAcrp on SIRT1 protein expression was tested in both RKC1 and RAW 264.7 cell lines by treating cells with various concentrations of gAcrp for 18 h. As shown in Fig.5A , in both cell lines, treatment with gAcrp significantly increased SIRT1 protein levels in a dose-dependent manner with a maximal effect at 2 μg/ml. While SIRT1 protein levels were significantly reduced by treatment with LPS (100 ng/ml) or acetate (20 mM), pre-incubation with gAcrp (2 μg/ml) for 1 hr partially or completely relieved the inhibition of SIRT1 protein expression caused by LPS or acetate in RKC1 cells (Fig.5B) .
To examine the effect of adiponectin on LPS-or acetate-induced TNFα secretion, RKC1 cells were pretreated with gAcrp (2 μg/ml) for 1 h, followed by stimulation with LPS (100 ng/ml) or acetate (20 mM) for 18 h. As shown in Fig.6 , marked increases in TNFα were produced by exposure of RKC1 to LPS or acetate. Pre-treatment with adiponectin partially, but significantly, attenuated TNFα production induced by LPS and completely blocked TNFα secretion stimulated by acetate. More importantly, inhibition of SIRT1 by overexpression of SIRT1shRNA plasmid abolished the inhibitory effect of adiponectin on TNFα, suggesting that the ability of adiponectin to regulate downstream TNFα production stimulated by LPS or acetate may occur, at least in part, through stimulating SIRT1 signaling (Fig.6) .
Similar results were generated in RAW 264.7 macrophages (data not shown).
Moreover, we attempted to measure the effect of gAcrp on AcH-mediated SIRT1 reduction and TNFα production, but the data did not reach statistical significance (data not shown).
DISCUSSION
In the present study, using cultured macrophage cell lines, we investigated the The precise mechanisms by which these molecules inhibit SIRT1 were not established in this study, but it is possible that they may all trigger a common molecular signaling cascade that ultimately impinges on SIRT1. If this is the case, then the reactive oxygen species (ROS) that are generated from Kupffer cells that are exposed to LPS or metabolites of ethanol are likely involved (3, 7, 32, 33) . Moreover, studies have shown that ethanol exposure increases LPS-stimulated NADPH oxidase-dependent production of ROS in Kupffer cells (25, 32) . Oxidative stress suppresses SIRT1 mRNA and protein expression levels (1, 35) . It is likely that LPS or metabolites of ethanol may downregulate SIRT1 through excess production of ROS.
Studies have shown that Kupffer cells isolated from livers of chronically ethanolfed animals were sensitized to LPS, responding with increased TNFα generation (4, 12, 25, 31, 32) . While several factors, such as activation of transcription factor early-growth response factor-1 (Egr-1), have been attributed to this effect, our current findings may provide additional explanations (17, 30) . Chronic ethanol administration inhibits activities of hepatic SIRT1 in mice and rats (2, 19, 20, 41, 42) . It is logical to speculate that, in chronically ethanol-fed animals, impaired hepatic SIRT1 signaling may prime and sensitize Kupffer cells to increase TNFα production in response to LPS.
In addition to NF-κB, activator protein-1 (AP-1) has also been shown to be The ability of resveratrol (a naturally occurring phenolic phytoalexin) to inhibit TNFα production in macrophages has been demonstrated by several studies (9, 18, 21) .
Our data shows that knocking-down SIRT1 largely blocks the inhibition of resveratrol on TNFα, suggesting that the inhibitory effect of SRT1 on TNFα may be, at least in part, mediated through activation of SIRT1. Several lines of evidence have suggested that activation of SIRT1 by resveratrol blocked the up-regulation of NF-κB signaling by stimulators such as TNFα or amyloid-beta (6, 29, 36, 38) . These studies further support our current findings that SIRT1 signaling is involved in the protective effects of resveratrol.
Furthermore, the action of resveratrol against TNFα generation stimulated by LPS or ethanol metabolites may explain its beneficial effects on ALD (2,15,16).
There is accumulating evidence that adiponectin suppresses LPS-stimulated TNFα production in Kupffer cells and in murine macrophages (24, 25) . Both transcriptional and post-transcriptional mechanisms have been suggested to mediate the action of adiponectin on LPS-stimulated TNFα release (24) . The present study suggests that adiponectin-SIRT1 signaling is also involved in these specific effects. Moreover, our observation that gAcrp treatment significantly increases SIRT1 protein expression levels in Kupffer cells is consistent with a report that gAcrp directly up-regulates SIRT1 in primary human myotubes (5) . Future studies are needed to elucidate a detailed mechanism of action of adiponectin on SIRT1 signaling.
Elevated levels of LPS and ethanol metabolites such as acetate and acetaldehyde are commonly associated with ethanol consumption and alcoholic liver injury (10, 22, 23, 31 
